Cite Filings / CGEM / 0001907884-26-000005
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

Cullinan Therapeutics, Inc. · Filed 2026-03-04 · Acc 0001907884-26-000005

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-03-10 S-8 Securities Offered to Employees in Benefit Plans
  • 2026-03-09 4 Chief Scientific Officer sold 8,000 shares at $15.68 ($125,440)
  • 2026-03-05 144 Sale of Securities
  • 2026-03-04 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-02-26 4 Chief Scientific Officer sold 1,780 shares at $14.14 ($25,169)
  • 2026-01-30 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…